The NRF2 involvement in various types of cancer was also studied, including breast cancer [55], prostate cancer [56,57], urinary bladder cancer [58], hepatic carcinoma [59], pancreatic cancer [60], non-small cell lung cancer [61], and colorectal cancer [62]. Here, NFE2L2 is linked to cancer.